PRICE T ROWE ASSOCIATES INC /MD/ - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2022$27,000
-20.6%
23,2000.0%0.00%
Q2 2022$34,000
-35.8%
23,2000.0%0.00%
Q1 2022$53,000
+60.6%
23,200
+95.0%
0.00%
Q4 2021$33,000
-81.8%
11,900
-68.0%
0.00%
Q2 2021$181,000
+47.2%
37,200
-25.0%
0.00%
Q1 2021$123,00049,6000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders